You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

53 Items

Organizational Requirements for Acute Leukemia Service Providers in Ontario: Recommendations Report 2024

Document Status: Current
Version: 2

Updated

Dec 2024

PET Imaging in Lymphoma

Document Status: Current
ID: PET 12

Mar 2015

Plerixafor for Autologous Hematopoietic Stem Cell Mobilization and Transplantation for Patients in Ontario

Document Status: Current
ID: SCT-7

Sep 2015

Positron Emission Tomography in Hodgkin Lymphoma Patients Undergoing Curative-Intent Treatment

Document Status: Current
ID: 27-4

Mar 2016

Rituximab in Chronic Lymphocytic Leukemia

Document Status: Archived
ID: CED 15

Nov 2009

Rituximab in Lymphoma and Chronic Lymphocytic Leukemia: A Clinical Practice Guideline

Document Status: Archived
ID: 6-8
Version: 3

Mar 2015

Safety Considerations for the Implementation of Subcutaneous Rituximab Formulation

Document Status: Current
Version: 1

Jun 2018

Screening for Secondary Solid Malignancies after Stem Cell Transplant

Document Status: Current
Version: 2

Mar 2022

Stem Cell Transplantation in Adults

Document Status: Archived
ID: SCT

Jan 2009

Stem Cell Transplantation in Lymphoma

Document Status: Archived
ID: SCT 4

Dec 2012

Stem Cell Transplantation in Multiple Myeloma

Document Status: In-Review
ID: SCT 1

Mar 2012

Stem Cell Transplantation in Myelodysplastic Syndromes and Acute Myeloid Leukemia

Document Status: In-Review
ID: SCT 3

Mar 2012